Whole-body rejuvenation drugs and AI news

This daily tech newsletter covers significant developments, including David Sinclair's plans to test whole-body rejuvenation drugs in the XPrize competition. Sinclair, a prominent longevity scientist, anticipates a future where such treatments are commonplace. The newsletter also provides five key insights into the rapidly evolving field of artificial intelligence, offering readers a concise overview of current trends and potential impacts. This edition aims to keep tech enthusiasts informed about both cutting-edge biological research and the latest advancements in AI.